MedPath
HSA Approval

TAMSIN PROLONGED RELEASE TABLET 0.4MG

SIN15476P

TAMSIN PROLONGED RELEASE TABLET 0.4MG

TAMSIN PROLONGED RELEASE TABLET 0.4MG

May 3, 2018

GOLDPLUS UNIVERSAL PTE LTD

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD
Licence HolderGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED, EXTENDED RELEASE

ORAL

Medical Information

G04CA02

tamsulosin

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

Synthon Hispania S.L.

GE Pharmaceuticals, Ltd. (Primary & Secondary Packager)

Rottendorf Pharma GmbH

Active Ingredients

Tamsulosin 0.367mg eqv Tamsulosin Hydrochloride

0.4mg

Tamsulosin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

TAMSIN PROLONGED RELEASE TABLET 0.4MG - HSA Approval | MedPath